This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.81% per year. These returns cover a period from January 1, 1988 through September 1, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Kellanova (K) Rallies on Q2 Earnings Beat, Raised Guidance
by Zacks Equity Research
Kellanova's (K) second-quarter 2024 results reflect the strength of the Pringles brand. The improved price/mix was also an upside, leading to organic sales and bottom-line growth.
Kraft Heinz (KHC) Cuts Sales View In Spite of Q2 Earnings Beat
by Zacks Equity Research
Kraft Heinz's (KHC) second-quarter 2024 results reflect lower sales and earnings on weakening consumer sentiment. Management lowers its 2024 organic net sales.
Diageo (DEO) FY24 Earnings & Sales Decline Y/Y on Soft Volume
by Zacks Equity Research
Diageo's (DEO) FY24 results reflect the impacts of soft volume particularly in LAC and North America, which hurt organic sales. Soft operating profit and higher costs hurt the bottom line.
Factors to Watch Before TreeHouse Foods' (THS) Q2 Earnings
by Zacks Equity Research
TreeHouse Foods' (THS) Q2 results are likely to reflect challenges such as the restart of the broth facility, along with the lag in pricing adjustments to counter cocoa inflation.
Mondelez (MDLZ) Q2 Earnings Top Estimates
by Zacks Equity Research
Mondelez (MDLZ) delivered earnings and revenue surprises of 10.26% and 0.59%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
Procter & Gamble (PG) Q4 Earnings Beat, Stock Down on Sales Miss
by Zacks Equity Research
Procter & Gamble's (PG) Q4 earnings reflect gains from improved volume and pricing, offset by adverse currency rates and higher costs, which impact its operating margin.
Lamb Weston (LW) Q4 Earnings & Sales Lag Estimates, Down Y/Y
by Zacks Equity Research
Lamb Weston's (LW) fourth-quarter fiscal 2024 results reflect lower earnings and sales on more-than-anticipated market share losses and a slowdown in restaurant traffic.
Inter Parfums' (IPAR) Q2 Sales Rise on Robust Fragrance Demand
by Zacks Equity Research
Inter Parfums' (IPAR) sales have increased year over year in second-quarter 2024, driven by ongoing momentum in the fragrance market.
Kimberly-Clark (KMB) Tops Q2 Earnings Estimates, Ups FY24 View
by Zacks Equity Research
Kimberly-Clark's (KMB) second-quarter 2024 results reflect higher earnings on increased operating profit. Taking into account solid first-half results, management raised its annual profit view.
Should Value Investors Buy TreeHouse Foods (THS) Stock?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
TreeHouse Foods (THS) Up 7% in a Month: What You Should Know
by Zacks Equity Research
TreeHouse Foods' (THS) efforts to enhance product offerings, improve supply chain efficiency, and execute growth plans bode well for its future prospects.
Philip Morris' (PM) New Investment to Fuel Smoke-Free Growth?
by Zacks Equity Research
Philip Morris' (PM) announcement of a $600 million investment to establish a manufacturing facility in Aurora, CO, presents several strategic advantages and promising growth opportunities.
Inter Parfums (IPAR) Gains on the Burgeoning Fragrance Market
by Zacks Equity Research
Continued momentum in the fragrance market and the successful product launches are driving Inter Parfums' (IPAR) growth story.
McCormick (MKC) Benefits From Brand Strength & Cost Savings
by Zacks Equity Research
With a global portfolio aligned with consumer trends and innovative product platforms, McCormick's (MKC) focus on growth areas and efficiency bolsters its market presence.
Energizer (ENR) Up 8.5% in 3 Months: How to Play Ahead?
by Zacks Equity Research
Energizer's (ENR) robust growth and financial health making it an attractive investment opportunity. Its strategic initiatives, particularly Project Momentum, have significantly improved cost efficiency and profitability.
Medifast (MED) Lags Industry in 3 Months: How to Play Ahead?
by Zacks Equity Research
While Medifast (MED) is implementing a series of measures to propel its growth trajectory, the challenges related to customer acquisition and high marketing expenses keep it in a tight spot.
The J.M. Smucker (SJM) Rewards Investors With Dividend Hike
by Zacks Equity Research
The J.M. Smucker (SJM) underlines its robust financial health and commitment to shareholders by announcing a 2% hike in its quarterly dividend.
United Natural (UNFI) Gains on Strong E-commerce Amid Setbacks
by Zacks Equity Research
United Natural's (UNFI) performance is positively impacted by its strong presence in e-commerce. The company is actively enhancing its supply chain processes.
Should Value Investors Buy Premier Foods (PRRFY) Stock?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
TreeHouse Foods' (THS) Strategic Efforts Aid Amid Challenges
by Zacks Equity Research
TreeHouse Foods (THS) remains committed to implementing TMOS and other supply-chain initiatives to enhance execution and margins.
B&G Foods (BGS) Up 14.4% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
B&G Foods (BGS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Why Is TreeHouse (THS) Up 4.2% Since Last Earnings Report?
by Zacks Equity Research
TreeHouse (THS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
TreeHouse Foods (THS) Looks Resilient on Private-Label Strength
by Zacks Equity Research
TreeHouse Foods (THS) benefits from strength in private-label groceries and a focus on TMOS and other supply-chain efforts amid cost inflation and near-term hurdles.
TreeHouse Foods (THS) Q1 Loss Wider Than Expected, Sales Dip Y/Y
by Zacks Equity Research
TreeHouse Foods' (THS) Q1 results reflect declines in the top and bottom lines, while emphasizing a strategic shift toward private brands and enhancing operational efficiencies.
TreeHouse Foods (THS) Reports Q1 Loss, Tops Revenue Estimates
by Zacks Equity Research
TreeHouse (THS) delivered earnings and revenue surprises of -50% and 2.92%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?